Results 21 to 30 of about 1,463,832 (396)

Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

JAMA Oncology, 2022
This multicenter, open-label randomized clinical trial conducted in China compares the efficacy and safety of adjuvant capecitabine with concurrent chemoradiotherapy vs concurrent chemoradiotherapy alone for treatment of patients with locoregionally ...
J. Miao, Lin Wang, S. Tan, Jin-Gao Li, J. Yi, E. Ong, L. Y. Tan, Ye Zhang, X. Gong, Qiu-Yan Chen, Yan-Qun Xiang, Ming-Yuan Chen, Ying Guo, X. Lv, W. Xia, Linquan Tang, Xiaowu Deng, Xiang Guo, F. Han, H. Mai, M. Chua, Chong Zhao   +21 more
semanticscholar   +1 more source

Radiomics in Nasopharyngeal Carcinoma [PDF]

Clinical Medicine Insights: Oncology, 2022
Nasopharyngeal carcinoma (NPC) is one of the most common head and neck malignancies, and the primary treatment methods are radiotherapy and chemotherapy. Radiotherapy alone, concurrent chemoradiotherapy, and induction chemotherapy combined with concurrent chemoradiotherapy can be used according to different grades. Treatment options and prognoses vary
Wenyue Duan, Bingdi Xiong, Ting Tian, Xinyun Zou, Zhennan He, Ling Zhang   +5 more
openaire   +3 more sources

Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape

Nature Communications, 2021
Interplay between EBV infection and acquired genetic alterations during nasopharyngeal carcinoma (NPC) development remains vague. Here we report a comprehensive genomic analysis of 70 NPCs, combining whole-genome sequencing (WGS) of microdissected tumor ...
J. Bruce, K. To, V. Lui, G. T. Chung, Y. Chan, C. Tsang, K. Yip, B. Ma, J. Woo, E. Hui, Michael K F Mak, S. Lee, C. Chow, S. Velapasamy, Yvonne Y Y Or, Pui Kei Siu, Samah El Ghamrasni, S. Prokopec, Man Wu, J. S. Kwan, Yuchen Liu, J. Chan, C. van Hasselt, L. Young, C. Dawson, I. Paterson, L. Yap, S. Tsao, Fei-Fei Liu, A. Chan, Trevor J Pugh, K. Lo   +31 more
semanticscholar   +1 more source

Alpha-fetoprotein–producing recurrent nasopharyngeal carcinoma: A case report

SAGE Open Medical Case Reports, 2021
Alpha-fetoprotein hardly increased due to nasopharyngeal cancer. In this article, we reported a 57-year-old male nasopharyngeal carcinoma patient who had posttreatment subscapular metastasis with high serum alpha-fetoprotein but negative plasma Epstein ...
Zhen-Chong Yang, Mei-Juan Luo, Li-Li Liu, Mu-Yan Cai, Yu-Jing Liang, Qiu-Yan Chen, Lin-Quan Tang, Hai-Qiang Mai   +7 more
doaj   +1 more source

Epstein–Barr Virus–Encoded Circular RNA CircBART2.2 Promotes Immune Escape of Nasopharyngeal Carcinoma by Regulating PD-L1

Cancer Research, 2021
This work demonstrates that circBART2.2 binding to RIG-I is essential for the regulation of PD-L1 and subsequent immune escape in nasopharyngeal carcinoma.
Junshang Ge, Jie Wang, F. Xiong, Xianjie Jiang, Kunjie Zhu, Yian Wang, Yongzhen Mo, Zhaojian Gong, Shanshan Zhang, Yi He, Xiayu Li, Lei Shi, Can Guo, Fuyan Wang, Ming Zhou, Bo Xiang, Yong Li, Gui-yuan Li, Wei Xiong, Zhaoyang Zeng   +19 more
semanticscholar   +1 more source

Nasopharyngeal Carcinoma

European Journal of Radiology, 2008
Imaging plays an important role in the staging of nasopharyngeal carcinoma. Accurate staging is necessary, as the treatment is directly dependent on stage. Clinical examination provides information on mucosal involvement but is unable to determine the deep extension or the presence of skull base invasion or intracranial spread.
Pier Paolo Claudio, David A. Denning
  +5 more sources

Nasopharyngeal Carcinoma

Surgical Oncology Clinics of North America, 2015
Nasopharyngeal carcinoma is uncommon in the United States, with only 0.2 to 0.5 cases per 100,00 people; this is in contrast to southern China and Hong Kong, where the incidence is 25 to 50 per 100,000 people. There is a potential link between Epstein-Barr virus and the development of nasopharyngeal carcinoma.
Sophia C, Kamran, Nadeem, Riaz, Nancy, Lee   +2 more
  +9 more sources

Symptomatic venous thromboembolism associated with peripherally inserted central catheters predicts a worse survival in nasopharyngeal carcinoma: results of a large cohort, propensity score–matched analysis

BMC Cancer, 2018
Background Despite increasing use, symptomatic venous thromboembolism (VTE) associated with peripherally inserted central catheter (PICC) is a common complication in nonmetastatic nasopharyngeal carcinoma (NPC) patients.
Yu-Jing Liang, Lin-Quan Tang, Xue-Song Sun, Yu-Ying Fan, Jin-Jie Yan, Yu-Yun Du, Shan-Shan Guo, Li-Ting Liu, Hao-Jun Xie, Sai-Lan Liu, Qing-Nan Tang, Xiao-Yun Li, Hai-Qiang Mai, Qiu-Yan Chen   +13 more
doaj   +1 more source

Nasopharyngeal carcinoma [PDF]

Orphanet Journal of Rare Diseases, 2006
Nasopharyngeal carcinoma (NPC) is a tumor arising from the epithelial cells that cover the surface and line the nasopharynx. The annual incidence of NPC in the UK is 0.3 per million at age 0-14 years, and 1 to 2 per million at age 15-19 years. Incidence is higher in the Chinese and Tunisian populations.
openaire   +4 more sources

Induction chemotherapy in the treatment of nasopharyngeal carcinoma: Clinical outcomes and patterns of care [PDF]

, 2018
The role of induction chemotherapy in nasopharyngeal carcinoma (NPC) remains controversial. The primary aim of this study was to use the National Cancer Database to evaluate the patterns of care of induction chemotherapy in NPC and its impact on overall ...
Adkins, Douglas, Barnes, Justin, Daly, Mackenzie D, Gabani, Prashant, Gay, Hiram A, Lin, Alexander J, Oppelt, Peter, Rich, Jason T, Rudra, Soumon, Thorstad, Wade L, Zevallos, Jose P   +10 more
core   +2 more sources